Amerant Bancorp Inc.
NYSE:AMTBBanks - Regional
+$0.25 today
- Market cap
- $1.13B
- Beta
- 0.90
- P/E (TTM)
- 14.9
- EPS (TTM)
- $1.57
- Dividend yield
- 1.53%
Volume 0.27M
Average 0.25M
AMTB Common Stock Issued
Cash raised by issuing new shares.
Amerant Bancorp Inc.NYSE: AMTB
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued turns negative
Q1 FY2026 common stock issued was -$594K, compared with $0 a year earlier. Trailing-twelve-month common stock issued was -$594K.
Context
- Common stock issued amounted to 0.0% of revenue in FY2025, down 27.1 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near -$594K or moves back toward the trailing-twelve-month quarterly average of -$148.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 155.75M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Issued vs competitors
How AMTB compares with its peers on the latest reported figures
- AMTB's LTM Mar 2026 common stock issued of $594K is the 5th largest of the 10 companies compared; the peer median is $35K.
- Its year-over-year change of -100.4% is the lowest of 6, against a peer median of -24.0%.
- Common stock issued amounts to 0.1% of revenue for AMTB, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $186.5M | — | — | 34.4% | |
HTBHomeTrust Bancshares, Inc. | LTM Mar 2026 | $1.16M | +181.8% | — | 0.4% |
| LTM Mar 2026 | $1.16M | -24.0% | +1.0% | 0.4% | |
| LTM Mar 2026 | $716K | -14.3% | +1.3% | 0.2% | |
| LTM Mar 2026 | $594K | -100.4% | — | 0.1% | |
| LTM Mar 2026 | $35K | -63.2% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMTB) | $35K | -24.0% | +1.1% | 0.0% | |
Competitors are the stored peer set for AMTB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 110.31M | 61.96M | 30.79M | (15.75M) | 51.62M |
| Depreciation & Amortization | 7.27M | 5.88M | 6.84M | 6.6M | 4.63M |
| Deferred Income Tax | 6M | 5M | (5.51M) | 165K | (1.1M) |
| Stock-Based Compensation | 4.78M | 5.79M | 6.78M | 5.05M | 3.57M |
| Change in Working Capital | 30.53M | 5.73M | (30.3M) | 168K | (20.46M) |
| Accounts Receivables | (4.43M) | (15.35M) | (34.45M) | 3.78M | 1.09M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 34.96M | 21.08M | 4.15M | (3.61M) | (21.54M) |
| Other Working Capital | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | (91.46M) | (133.52M) | 18.13M | 85.97M | 62.24M |
| Operating Cash Flow | 67.43M | (49.16M) | 26.72M | 82.19M | 100.5M |
| Capital Expenditures | (6.58M) | (10.63M) | (10.93M) | (7.4M) | (2.53M) |
| Acquisitions (Net) | (1.04M) | 0 | (1.97M) | (73.91M) | 0 |
| Purchases of Investments | (526.27M) | (419.35M) | (266.59M) | (735.61M) | (913.03M) |
| Sales of Investments | 509.6M | 262M | 130.08M | 703.7M | 153.42M |
| Other Investing Activities | 409.6M | (1.23B) | (457.2M) | (463.44M) | 261.05M |
| Investing Cash Flow | 385.32M | (1.4B) | (606.62M) | (576.66M) | (501.1M) |
| Debt Repayment | (244.12M) | 134.82M | (221.98M) | 101.62M | 26.61M |
| Common Stock Issued | 0 | 0 | 0 | 155.75M | 0 |
| Common Stock Repurchased | (48.04M) | (72.06M) | (4.93M) | (7.56M) | (20M) |
| Dividends Paid | 0 | (12.23M) | (12.06M) | (12.82M) | (11.41M) |
| Other Financing Activities | (100.77M) | 1.41B | 850.14M | 525.97M | 445.89M |
| Financing Cash Flow | (392.93M) | 1.46B | 611.17M | 762.96M | 441.1M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 59.82M | 16.39M | 31.27M | 268.49M | 40.5M |
| Free Cash Flow | 60.85M | (59.79M) | 15.79M | 74.79M | 97.96M |
Amerant Bancorp Inc.
NYSE:AMTB
Intrinsic Alpha fair value
Locked
Current Price
$28.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.